Analyst firms · Morgan Stanley · MRK
Morgan Stanley MRK price target and rating history
Merck & Company Inc. (MRK) · Health Care
Morgan Stanley rates Merck & Company Inc. (MRK) Overweight with a $179 price target, as of its latest action on Aug 20, 2026. It has published 6 rating actions on MRK since September 2021, including 1 upgrade and 1 downgrade. Across 10 firms with a MRK price target in the last 12 months, the median target is $141.50. Morgan Stanley's $179 is 27% above that.
- Current rating
- Overweight
- Price target
- $179
- Median target, all firms
- $141.50
- Actions on MRK
- 6
Morgan Stanley price target on MRK
Every Morgan Stanley rating on MRK
- Aug 20, 2026
- Apr 6, 2022
- Nov 29, 2021
- Oct 29, 2021
- Oct 12, 2021
- Sep 7, 2021
How other firms rate MRK
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| DZ Bank | Hold | $153 | Nov 3, 2026 |
| RBC Capital Markets | Sector Perform | $150 | Aug 20, 2026 |
| Morgan Stanley | Overweight | $179 | Aug 20, 2026 |
| Daiwa | Outperform | $143 | Aug 12, 2026 |
| Citigroup | Neutral | $125 | May 6, 2026 |
| Barclays | Overweight | $140 | Feb 20, 2026 |
| Deutsche Bank | Buy | $150 | Feb 13, 2026 |
| Wolfe Research | Outperform | $135 | Jan 8, 2026 |
| BMO Capital Markets | Outperform | $130 | Dec 18, 2025 |
| Wells Fargo | Overweight | $125 | Nov 24, 2025 |
Questions about Morgan Stanley and MRK
- What is Morgan Stanley's price target for MRK?
- Morgan Stanley's latest stated price target for Merck & Company Inc. (MRK) is $179, from its action on Aug 20, 2026.
- What is Morgan Stanley's rating on MRK?
- Morgan Stanley rates MRK Overweight, a bullish rating, as of Aug 20, 2026.
- When did Morgan Stanley last change its view on MRK?
- On Aug 20, 2026, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $179.
- How does Morgan Stanley's MRK target compare with other analysts?
- Across 10 firms with a MRK price target in the last 12 months, the median target is $141.50. Morgan Stanley's $179 is 27% above that.
More MRK rating histories
- Daiwa4
- Citigroup5
- Barclays3
- Deutsche Bank3
- Wolfe Research3
- BMO Capital Markets4
- Wells Fargo3
- Berenberg3
- Leerink Partners5
All Morgan Stanley ratingsMRK news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.